Ethylene oxide sterilizes effectively, but it leaves residuals behind. Managing those residuals is a core part of EO validation and a frequent driver of timeline — and it is governed by ISO 10993-7.
What residuals form
EO processing can leave residual ethylene oxide (EO) and ethylene chlorohydrin (ECH) on and within a device. Because both are toxicologically significant, ISO 10993-7 sets allowable limits based on the device’s category and duration of patient contact.
How residuals are controlled
Aeration is the primary control: after sterilization, devices are held under controlled temperature and airflow so residuals off-gas to within ISO 10993-7 limits. The required aeration time depends on the device materials, packaging, and load configuration, and it is established during validation.
Why in-house residual testing matters
Residual testing on the EO/ECH side is often a hidden bottleneck when samples have to ship to an outside lab. Performing residual testing in the same building as sterilization keeps the data tightly coupled to the process and removes inter-vendor shipping from the release timeline.
The residual-free alternative
For teams where aeration time or residual risk is a recurring obstacle, chlorine dioxide leaves no carcinogenic residuals of concern and requires no long aeration hold. It is one of the strongest reasons device makers evaluate CD as an EO alternative — and because we run both, we can compare them on your actual device.
Related Articles
Ready to scope your sterilization project?
Boulder Sterilization runs both EO and chlorine dioxide, co-located with cleanroom assembly, packaging, and in-house biological testing. Talk to us about your device.
Request a Quote